Antiplatelet therapy in aneurysmal subarachnoid hemorrhage a systematic review

Stroke

Volumn 34, Issue 9, 2003, Pages 2285-2289

  Mees, Sanne M Dorhout ^a   Rinkel, Gabriel J E ^a,b   Hop, Jeannette W ^a   Algra, Ale ^a,b   Van Gijn, Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Aneurysm; Antiplatelet therapy; Subarachnoid hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; MANNITOL; METHYLPREDNISOLONE; NIMODIPINE; NIZOFENONE; OZAGREL; PLACEBO; STEROID; TRANEXAMIC ACID;

ANEURYSM; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CALCULATION; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HUMAN; LITERATURE; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; MORTALITY; NEUROSURGERY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

BRAIN ISCHEMIA; HUMANS; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; RISK; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 0042418480     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000083621.44269.3E     Document Type: Review

References (35)

1. Findlay JM, Macdonald RL, Weir BK. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab. 1991;3:336-361.
2. Dorsch NW. Cerebral arterial spasm: a clinical review. Br J Neurosurg. 1995;9:403-412.
3. Juvela S, Hillbom M, Kaste M. Platelet thromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage. J Neurosurg. 1991;74:386-392.
4. Ohkuma H, Suzuki S, Kimura M, Sobata E. Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke. 1991;22:854-859.
5. 2 levels in serum during continuous administration of nimodipine to patients with aneurysmal subarachnoid hemorrhage. Stroke. 1988;19:644-647.
6. Honma Y, Clower BR, Haining JL, Smith RR. Comparison of intimal platelet accumulation in cerebral arteries in two experimental models of subarachnoid hemorrhage. Neurosurgery. 1989;24:487-490.
7. Ohkuma H, Ogane K, Fujita S, Manabe H, Suzuki S. Impairment of anti-platelet-aggregating activity of endothelial cells after experimental subarachnoid hemorrhage. Stroke. 1993;24:1541-1546.
8. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med. 1994;330: 1287-1294.
9. 2 and prostacyclin. Stroke. 1992;23:1400-1403.
10. Kawakami M, Kodama N, Toda N. Suppression of the cerebral vasospastic actions of oxyhemoglobin by ascorbic acid. Neurosurgery. 1991; 28:33-39.
11. Juvela S. Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1995;82:945-952.
12. 2. Neurosurgery. 1981;9:679-685.
13. 2 synthetase on cerebral vasospasm after early surgery. J Neurosurg. 1984;61: 24-29.
14. Suzuki S, Iwabuchi T, Tanaka T, Kanayama S, Ottomo M, Hatanaka M, Aihara H. Prevention of cerebral vasospasm with OKY-046 an imidazole derivative and a thromboxane synthetase inhibitor: a preliminary co-operative clinical study. Acta Neurochir (Wien). 1985;77:133-141.
15. 2 synthetase inhibitor and hyperdynamic therapy. Acta Neurochir (Wien). 1993:125:15-19.
16. Hirashima Y, Takashima S, Matsumura N, Kurimoto M, Origasa H, Endo S. Right sylvian fissure subarachnoid hemorrhage has electrocardiographic consequences. Stroke. 2001;32:2278-2281.
17. Korosue K, Kondoh T, Ishikawa A, Suzuki H, Nagao T, Tamaki N, Matsumoto S. [Lipo prostaglandin E1 administration in the acute stage following subarachnoid hemorrhage]. No Shinkei Geka. 1988:16(suppl): 509-515.
18. 2 synthetase inhibitor (OKY-046): clinical study among multiple institutions]. Nippon Geka Hokan. 1986;55:473-484.
19. Mendelow AD, Stockdill G, Steers AJ, Hayes J, Gillingham FJ. Double-blind trial of aspirin in patient receiving tranexamic acid for subarachnoid hemorrhage. Acta Neurochir (Wien). 1982;62:195-202.
20. Shaw MD, Foy PM, Conway M, Pickard JD, Maloney P, Spillane JA, Chadwick DW. Dipyridamole and postoperative ischemic deficits in aneurysmal subarachnoid hemorrhage. J Neurosurg. 1985;63:699-703.
21. Suzuki S, Sano K, Handa H, Asano T, Tamura A, Yonekawa Y, Ono H, Tachibana N, Hanaoka K. Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischemic symptoms after subarachnoid hemorrhage due to aneurysmal rupture: a randomized double-blind study. Neurol Res. 1989; 11:79-88.
22. Tokiyoshi K, Ohnishi T, Nii Y. Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage. Surg Neurol. 1991;36:112-118.
23. Hop JW, Rinkel GJE, Algra A, Berkelbach van der Sprenkel JW, van Gijn J. Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage. Neurology. 2000;54:872-878.
24. Vermeulen M, Lindsay KW, Murray GD, Cheah F, Hijdra A, Muizelaar JP, Schannong M, Teasdale GM, van Crevel H, van Gijn J. Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med. 1984; 311:432-437.
25. Findlay JM, Lougheed WM, Gentili F, Walker PM, Glynn MF, Houle S. Effect of perioperative platelet inhibition on postcarotid endarterectomy mural thrombus formation: results of a prospective randomized controlled trial using aspirin and dipyridamole in humans. J Neurosurg. 1985;63: 693-698.
26. Lindblad B, Persson NH, Takolander R, Bergqvist D. Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomized trial. Stroke. 1993;24:1125-1128.
27. Yende S, Wunderink RG. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med. 2001;29:2271-2275.
28. Ferraris VA, Ferraris SP, Joseph O, Wehner P, Mentzer RMJ. Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg. 2002;235:820-827.
29. Hongo RH, Ley J, Dick SE, Yee RR. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol. 2002;40:231-237.
30. Tuman KJ, McCarthy RJ, O'Connor CJ, McCarthy WE, Ivankovich AD. Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery. Anesth Analg. 1996;83:1178-1184.
31. Dacey LJ, Munoz JJ, Johnson ER, Leavitt BJ, Maloney CT, Morton JR, Olmstead EM, Birkmeyer JD, O'Connor GT. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg. 2000;70:1986-1990.
32. Brilstra EH, Rinkel GJE, Algra A, van Gijn J. Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology. 2000;55:1656-1660.
33. Patrono C, Davi G, Ciabattoni G. Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors. Agents Actions Suppl. 1992;37:10-17.
34. Naito J, Komatsu H, Ujiie A, Hamano S, Kubota T, Tsuboshima M. Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets. Eur J Pharmacol. 1983;91:41-48.
35. Harker LA, Kadatz RA. Mechanism of action of dipyridamole. Thromb Res Suppl. 1983;4:39-46.